VECA-RI — Vernal Capital Acquisition Corp.

NYSE · Financials · Diversified Financial Services · CIK 2081690 · Singapore
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $4.94B $38.67
DMII Drugs Made In America Acquisition II Corp. $642.10M $10.08
INV Innventure, Inc. $491.66M $5.85
BCSS Bain Capital GSS Investment Corp. $479.79M $10.23
EVAC EQV Ventures Acquisition Corp. II $477.69M $10.18

Recent Insider Activity

No insider activity indexed for this ticker.